The Academy is pleased to publish an important piece of news from Honorio Silva, MD in regards to the completion of the 2024 academic year.

Pravin Chopra and Jacob Coots, Module Chair and Interim CEO, and Director of Operations respectively, announced the finalization of all academic activities related to Module 6 (“Medical Affairs as a strategic business partner”) with outstanding markings in terms of knowledge gain and satisfaction with the program. The next request to receive the professional certification was an Essay about Professional Identity and Sense of Purpose in Medicines Development, (like the one published at point 1 and related to the 2023 class) requested for submission by November 27. The interim results of the 2024 program are comparable to those from past years, which are summarized as follows:

  • Seven annual cohorts, 682 participants from 86 countries were enrolled in the program.
  • The program was assessed using classic Kirkpatrick Model, showing elevated levels of satisfaction (over 4.0) on a five-point scale, significant gains in competence at the cognitive level and leveraged performance.
  • Notably 70 % of alumni reported significant improvements in their job duties, corroborated by 30 % of their supervisors.
  •  A similar report for the 2024 cohort is thus expected.

We look forward to the Academy continuing to contribute to life-long learning in Medicines Development, addressing educational gaps and fostering interdisciplinary collaboration. Our success highlights the importance of lifelong learning in keeping pace with the industry’s evolving demands and underscores the potential of blended learning in achieving educational objectives in pharmaceutical medicine.

The professional and academic certification by the GMDP Academy and King’s College London would help in creating awareness of the value of forming competent health professionals to advancing medicines development and leveraging health globally.

Don’t miss out. Apply now for the 2025 CMD program!

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred